MAIN


©1996-2019. All Rights Reserved. Online Journal of Bioinformatics . You may not store these pages in any form except for your own personal use. All other usage or distribute on is illegal under international copyright treaties. Permission to use any of these pages in any other way besides the  before mentioned must be gained in writing from the publisher. This article is exclusively copyrighted in its entirety to OJB publications. This article may be copied once but may not be, reproduced or  re-transmitted without the express permission of the editors. This journal satisfies the refereeing requirements (DEST) for the Higher Education Research Data Collection (Australia). Linking:To link to this page or any pages linking to this page you must link directly to this page only here rather than put up your own page.


OJBTM

Online Journal of Bioinformatics ©

Volume 12(1):66-73, 2011


Partial sequence clone of canine mammary tumor metalloproteinase MMP11 catalytic domain

 

B. V. Sunil Kumar (M.V.Sc), Meena Kataria (M.Sc,Ph.D), G.V.P.P.S. Ravi Kumar*(M.V.Sc,Ph.D), K. Aswani Kumar (M.V.Sc)

and A.P. Vishwanatha Reddy

 

Enzymology lab., Division of Biochemistry, Indian Veterinary Research Institute, Izatnagar, Bareilly-243122 (U.P.), India.

 

ABSTRACT

 

Sunil Kumar BV, Kataria M, Kumar R, Kumar KA, Vishwanatha Reddy AP, Partial sequence clone of canine mammary tumor metalloproteinase MMP11 catalytic domain, Onl J Bioinform., 12(1):66-73, 2011. Partial sequence of canine MMP11 catalytic domain was cloned and sequenced (Acc o.HM037636). Nucleotide and translated protein sequence was close to Equus caballus but clustered away from rodent and primate groups. Synonymous substitution (dS) was higher than non-synonymous substitution (dN) suggesting that the catalytic domain MMP11 gene was not under positive selection and that no advantageous mutations had had any significant role in its evolutionary adaptation.

 

(Key words: Cloning, Characterization, Matrix metalloproteinase 11, canine.


MAIN

 

FULL-TEXT(SUBSCRIPTION OR PURCHASE TITLE $25USD)